Citalopram Export Market Intelligence: India's 257 Suppliers Shipping to 101 Countries — TransData Nexus 2026

Q: Who are the top citalopram exporters from India?

The top citalopram exporters from India are: 1. MEDISPRAY LABORATORIES PRIVATE LIMITED — $77.6M (30.5% market share); 2. AUROBINDO PHARMA LTD — $28.0M (11.0% market share); 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $23.0M (9.0% market share); 4. TORRENT PHARMACEUTICALS LTD — $21.7M (8.5% market share); 5. MYLAN LABORATORIES LIMITED — $17.3M (6.8% market share). Together they account for 65.8% of India's total citalopram export value.

Q: What is the total export value of citalopram from India?

The total export value of citalopram from India is $254.5M USD, recorded across 7,372 shipment transactions from 257 active exporters to 101 destination countries. The average shipment value is $34.5K.

Q: Which countries import citalopram from India?

India exports citalopram to 101 countries worldwide. The top importing countries are: MOROCCO (31.6% share, $80.4M), UNITED STATES (28.8% share, $73.4M), BELGIUM (4.7% share, $12.0M), BRAZIL (4.2% share, $10.7M), CANADA (4.0% share, $10.1M). These five markets account for 73.3% of total export value.

Q: What is the HS code for citalopram exports from India?

The primary HS code for citalopram exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of citalopram exports from India?

The average unit price for citalopram exports from India is $3.57 USD per unit, with prices ranging from $0.00 to $978.18 depending on formulation, packaging, and order volume. The total market is valued at $254.5M across 7,372 shipments.

Q: Which ports handle citalopram exports from India?

The primary ports for citalopram exports from India are SAHAR AIR CARGO ACC (INBOM4) (10.6% of shipments), SAHAR AIR (9.3% of shipments), NHAVA SHEVA SEA (INNSA1) (8.3% of shipments), HYDERABAD ICD (8.0% of shipments), HYDERABAD ICD (INSNF6) (5.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of citalopram?

India is one of the world's leading exporters of citalopram due to its large base of 257 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports citalopram to 101 countries, demonstrating 52% global market coverage.

Q: What certifications do Indian citalopram exporters need?

Indian citalopram exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import citalopram from India?

There are 736 registered buyers importing citalopram from India, spread across 101 countries. The repeat buyer rate is 69.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top citalopram supplier from India?

MEDISPRAY LABORATORIES PRIVATE LIMITED is the leading citalopram exporter from India with a market share of 30.5% and total export value of $77.6M across 77 shipments. The top 5 suppliers together control 65.8% of total export value.

Suresh Sormare

Citalopram

India Pharmaceutical Trade Intelligence

$254.5M257 Suppliers101 CountriesHS 30049099

ExportsIndia → MOROCCO31.6%India → UNITED STATES28.8%

ImportsCANADA → India$5.3M UNITED STATES → India$24.9K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Citalopram Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Citalopram to the World

Between 2022 and 2026, India exported $254.5M worth of citalopram across 7,372 verified shipments to 101 countries — covering 52% of world markets in the CNS & Psychiatric segment. The largest destination is MOROCCO (31.6%). MEDISPRAY LABORATORIES PRIVATE LIMITED leads with a 30.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Citalopram export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Citalopram export data snapshot — $254.5M · 257 exporters · 101 countriesTransData Nexus · Indian Customs Data

Top Citalopram Exporters from India

257 active exporters · Ranked by export value

View all 257 →

Top Citalopram Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MEDISPRAY LABORATORIES PRIVATE LIMITED	$77.6M	77	1	30.5%
2	AUROBINDO PHARMA LTD

Top Countries Importing Citalopram from India

101 destination markets · Ranked by import value

All 101 countries →

Top Countries Importing Citalopram from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	MOROCCO	$80.4M	31.6%
2	UNITED STATES	$73.4M	28.8%
3	BELGIUM	$12.0M	4.7%
4	BRAZIL	$10.7M	4.2%
5	CANADA	$10.1M	4.0%
6	AUSTRALIA	$9.4M	3.7%
7	UNITED KINGDOM	$8.4M	3.3%
8	SOUTH AFRICA	$7.0M	2.7%
9	POLAND	$6.9M	2.7%
10	MALTA	$5.2M	2.0%

MOROCCO is India's largest citalopram export destination, absorbing 31.6% of total exports worth $80.4M. The top 5 importing countries — MOROCCO, UNITED STATES, BELGIUM, BRAZIL, CANADA — together account for 73.3% of India's total citalopram export value. The remaining 96 destination countries collectively receive the other 26.7%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Citalopram to India?

14 origin countries · Total import value: $5.3M

India imports citalopram from 14 countries with a combined import value of $5.3M. The largest supplier is CANADA ($5.3M, 31 shipments), followed by UNITED STATES and MALTA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Citalopram to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CANADA	$5.3M	31	99.0%
2	UNITED STATES	$24.9K	45	0.5%
3	MALTA	$9.8K	37	0.2%
4	DENMARK	$4.9K	5	0.1%
5	GERMANY	$3.1K	17	0.1%
6	SOUTH AFRICA	$2.4K	2	0.0%
7	BRAZIL	$2.3K	7	0.0%
8	UNITED KINGDOM	$1.2K	4	0.0%
9	HUNGARY	$970	7	0.0%
10	BULGARIA	$938	11	0.0%

Showing top 10 of 14 origin countries

CANADA is the largest supplier of citalopram to India, accounting for 99.0% of total import value. The top 5 origin countries — CANADA, UNITED STATES, MALTA, DENMARK, GERMANY — together supply 99.8% of India's citalopram imports. Click any country to see detailed supplier and buyer data for that import corridor.

Citalopram — Export Intelligence Video

Visual overview of India's citalopram import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's citalopram pharmaceutical import and export market — $254.5M in total trade, 257 verified manufacturers, and 101 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Citalopram

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, citalopram is approved for the treatment of depression. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for citalopram, indicating a competitive generic market. Notably, the FDA issued a safety communication in August 2011, highlighting that doses above 40 mg per day can cause abnormal heart rhythms, leading to a revision of dosing recommendations. As of March 2026, there are no active FDA import alerts specifically targeting citalopram from Indian manufacturers, suggesting compliance with U.S. regulatory standards.

2EU & UK Regulatory Framework

In the European Union, citalopram is authorized for marketing under the centralized procedure managed by the European Medicines Agency (EMA). The UK's Medicines and Healthcare products Regulatory Agency (MHRA) also oversees citalopram's approval and monitoring. Manufacturers exporting to these regions must adhere to Good Manufacturing Practice (GMP) standards as outlined in EU Directive 2003/94/EC. Compliance with these standards is essential for maintaining market authorization and ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Citalopram is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality specifications across different regions.

4India Regulatory Classification

In India, citalopram is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, citalopram is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with international trade regulations.

5Patent & Exclusivity Status

The primary patents for citalopram have expired, leading to a robust generic market. This expiration has facilitated the entry of multiple generic manufacturers, intensifying competition and contributing to the drug's affordability and widespread availability.

6Recent Industry Developments

In June 2025, the NPPA conducted a review of antidepressant pricing, including citalopram, to assess market dynamics and ensure fair pricing practices. In September 2025, the CDSCO issued updated guidelines for the export of pharmaceutical products, emphasizing stringent quality control measures to align with international standards. In December 2025, the WHO updated its Essential Medicines List, reaffirming the inclusion of citalopram, highlighting its continued relevance in global mental health treatment protocols.

These developments reflect the dynamic regulatory landscape governing citalopram, emphasizing the importance of compliance with international standards to maintain market access and ensure patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Citalopram

Retail & reference prices across 9 markets vs. India FOB export price of $3.57/unit

Global Price Benchmark for Citalopram across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, generic versions of citalopram are widely available, contributing to lower prices.
United Kingdom	$0.05	GBP	The NHS Drug Tariff lists citalopram 20 mg tablets at £0.04 each as of March 2026.
Germany	$0.06	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceutical pricing, ensuring affordability.
Australia	$0.06

Supply Chain Risk Assessment — Citalopram

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Citalopram, a widely prescribed antidepressant, relies on Active Pharmaceutical Ingredients (APIs) that are predominantly manufactured in India. However, the production of these APIs is heavily dependent on Key Starting Materials (KSMs) and intermediates imported from China. This dependency poses a significant risk, as any disruption in the supply chain from China can directly impact the availability of citalopram. For instance, in November 2025, geopolitical tensions led to temporary export restrictions from China, causing delays in the supply of critical KSMs to Indian manufacturers.

Recognizing this vulnerability, the Indian government has implemented the Production Linked Incentive (PLI) Scheme for Bulk Drugs, aiming to bolster domestic production of 41 critical KSMs, DIs, and APIs. As of September 2025, this initiative has resulted in the establishment of manufacturing capacities for 26 KSMs and APIs, leading to cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore. Despite these efforts, the transition to self-reliance is ongoing, and the industry remains susceptible to external supply chain disruptions.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of citalopram from India account for 65.8% of the total export value, with MEDISPRAY LABORATORIES PRIVATE LIMITED alone contributing 30.5%. This high supplier concentration introduces a single-source risk, where operational or financial issues within these key companies could significantly disrupt the global supply of citalopram.

Access Complete Citalopram Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 7,372 transactions across 101 markets.

Request Demo View Pricing

Frequently Asked Questions — Citalopram Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top citalopram exporters from India?

The leading citalopram exporters from India are MEDISPRAY LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, and 12 others. MEDISPRAY LABORATORIES PRIVATE LIMITED leads with 30.5% market share ($77.6M). The top 5 suppliers together control 65.8% of total export value.

What is the total export value of citalopram from India?

The total export value of citalopram from India is $254.5M, recorded across 7,372 shipments from 257 active exporters to 101 countries. The average shipment value is $34.5K.

Which countries import citalopram from India?

India exports citalopram to 101 countries. The top importing countries are MOROCCO (31.6%), UNITED STATES (28.8%), BELGIUM (4.7%), BRAZIL (4.2%), CANADA (4.0%), which together account for 73.3% of total export value.

What is the HS code for citalopram exports from India?

The primary HS code for citalopram exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Citalopram

Citalopram

Top Citalopram Exporters from India

Top Countries Importing Citalopram from India

Who Supplies Citalopram to India?

Quick Facts

Related CNS & Psychiatric

Related Analysis

Need Details?

Citalopram — Export Intelligence Video

Regulatory Landscape — Citalopram

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Citalopram

Supply Chain Risk Assessment — Citalopram

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Citalopram Trade Intelligence

Frequently Asked Questions — Citalopram Exports from India

Who are the top citalopram exporters from India?

What is the total export value of citalopram from India?

Which countries import citalopram from India?

What is the HS code for citalopram exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of citalopram exports from India?

Which ports handle citalopram exports from India?

Why is India a leading exporter of citalopram?

What certifications do Indian citalopram exporters need?

How many buyers import citalopram from India?

What is the market share of the top citalopram exporter from India?

Analysis Methodology